Brellium
New York
About Brellium
Brellium operates as an AI-powered clinical compliance platform that automates chart review across every patient visit, ensuring documentation aligns with payor, clinical quality, and billing standards. It proactively identifies issues like inaccurate MDM/E&M coding, cloned notes, inconsistent session lengths, and other documentation errors, providing instant feedback to clinical teams along with correction guidance. The platform integrates with EMRs, supports advanced analytics on chart data, and includes a “clawback protection” feature where Brellium assumes financial responsibility for reimbursements denied due to compliance lapses in approved charts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $27.8M
- Funding stage: Early Stage Venture
- Last round: Series A (Mar 2025)
- Website: brellium.io
- Phone: +1 661-733-0036
Industries & Categories
Artificial Intelligence (AI), Billing, Enterprise Software, SaaS
Social Profiles
Canonical: https://fsome.com/organization/brellium-59930 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.